WE SAY THE UGLY PART.Wednesday, October 21, 2026JUST THE FUCKING FACTS
EST. 2026
THE UNFILTERED EDITION
The news.
Minus the bullshit.
← Business
CommentaryGENITAL ILLITERACY

FDA Tells Herpe Cream Grifters: Your Spelling Is a Public Health Hazard

The agency sent a 'read receipt requested' email to RoyceDerm LLC, stating its unapproved 'Herpes Relief Cream' - promoted with genital-hand photos and a URL that misspells 'herpes' five times - could lead trusting customers to infertility, sepsis, or death.

Sheridan County building
IreneWyo / Wikimedia Commons, CC BY-SA 3.0

The facts

On October 1, 2026, the FDA's Center for Drug Evaluation and Research sent warning letter MARCS-CMS 734781 to RoyceDerm LLC, a company whose letterhead lists a recipient address of 1309 Coffeen Avenue, Ste 3000, Sheridan, Wyoming, and a second address of 255 Primera Blvd, Ste 160, Lake Mary, Florida. The delivery method was "VIA ELECTRONIC MAIL READ/DELIVERY RECEIPT REQUESTED", which is the federal government's way of saying you cannot pretend you never saw this email.

The agency reviewed the company's website, https://roycederm.com/, in July 2026 and concluded that the company's "Herpes Relief Cream" is an unapproved new drug under section 505(a) of the Federal Food, Drug, and Cosmetic Act. The letter says unapproved drug products marketed for the treatment of sexually transmitted infections and sold directly to consumers "present a serious public health concern", because people who rely on them "may forgo timely, appropriate medical care, increasing their risk of severe complications such as infertility, sepsis, and death", and may "unknowingly transmit infections to their partners." The FDA states it has not approved any over-the-counter drug product for the treatment, cure, mitigation, or prevention of any STI, and that effective treatment requires diagnosis and supervision by a licensed healthcare professional.

As evidence of intended use, the letter quotes the product's own labeling: "RoyceDerm Herpes Relief Cream is specially formulated to help relieve the symptoms of Herpes, rashes or blisters, redness & pain." The label also promises that the cream "Fights outbreaks" "Soothes & cools" and "Reduces recurrence" The FDA further describes a product page headlined "NATURAL GENTLE RELIEF CREAM FOR HERPES SUFFERERS", illustrated with "images of what appear to be a man and woman with their hands over their genital region" plus "before" and "after" images of what appears to be herpes lesions on the skin. The page's own URL spells the disease wrong five times: https://roycederm.com/products/herpe-treatment-cream-herpe-treatment-for-women-natural-herpe-treatment-genital-gentle-cream-for-herpe-sufferers-genital-herpe-symptoms.

The FDA gave RoyceDerm fifteen (15) business days to respond to FDAAdvisory@fda.hhs.gov with reference number "734781" in the subject line, warning that failure to fix the violations could bring seizure and injunction. The letter is signed by Tina Smith, M.S., Captain, U.S. Public Health Service, Director of the Office of Unapproved Drugs and Labeling Compliance. A copy went to Everymarket Inc. of O'Fallon, Missouri.

Our take

What a beautiful, stupid fucking crime. You need a special kind of brain damage to sell a cream for a disease you can’t spell, but RoyceDerm LLC built its entire digital storefront around the word “herpe.” The product page URL uses that pathetic, half-finished abortion of a word five fucking times. It’s the linguistic equivalent of trying to wipe your ass with a wet napkin and missing. The FDA’s compliance officers had to copy that URL into an official warning letter, a task that probably caused more psychic damage than reviewing the before-and-after photos of herpes lesions they also had to describe.

And what marketing! The page features “images of what appear to be a man and woman with their hands over their genital region.” Not holding flowers, not smiling at a sunset - just two people clutching their crotches like they’re trying to keep their ghosts from escaping. It’s the visual language of a grifter who thinks “subtlety” is something you put on a sandwich. The cream promises to “Fight outbreaks” and “Reduce recurrence,” which is about as medically useful as fighting a forest fire with a squirt gun full of your own piss.

But the real shit here isn’t the comedy; it’s the consequence. The FDA says this unapproved bullshit presents a “serious public health concern” because dumb fucks who buy it might skip real doctors. That means some poor bastard with an actual infection rubbed this Wyoming snake oil on his dick instead of getting treatment, risking infertility, sepsis, or death. RoyceDerm wasn’t just peddling false hope; it was peddling a misspelled, genital-clutching pathway to the grave.

The letter was sent “VIA ELECTRONIC MAIL READ/DELIVERY RECEIPT REQUESTED.” Think about that. Some lawyer in a Florida strip-mall office opened this email, saw the federal government’s clinical description of crotch photos and a “herpe” URL, and had to click Yes, I have received this evidence of my client’s profound illiteracy and lethal negligence. That read-receipt click is a more profound humiliation than any court injunction. It’s the sound of a grifter’s soul leaving his body through his asshole.

The company has fifteen business days to respond. We suggest they use that time to learn how to spell the name of the disease they’re monetizing, or maybe just to fuck off forever. Selling magic cream for a scary infection is one thing. Selling it with a URL that looks like a keyboard malfunction is the act of a true, world-class cunt.

Sources

01FDA: RoyceDerm LLC - 734781 - 10/01/202602Wikimedia Commons: Sheridan County Courthouse in Sheridan Wyoming - 2013-07-06.jpg
NEXT UP WorldMacron's Fuel-Begging Tour Upgraded to International Whine-Tasting

WHILE YOU’RE HERE.

Business/CHEAPEST SHIT THAT DOESN'T KILL YOU, ON PAPER

The VA Wrote Down That Late Surgery Packs Could Cancel Veterans' Surgeries, Then Said Getting Them Faster Had "no value"

The Court of Federal Claims just ordered the VA to redo its $98.5 million sterile-procedure-pack solicitation. The agency shopped by lowest price technically acceptable, wrote into its own acquisition plan that late packs could delay or cancel surgeries, and then told the court a faster delivery plan was worth "no value" to it. Senior Judge Loren A. Smith was not buying it.